Combination therapy for acute respiratory viral infections from the perspective of a clinical pharmacologist
https://doi.org/10.21518/2079-701X-2018-6-66-70
Abstract
Despite numerous activities, healthcare efforts and scientific advances, acute respiratory viral infections (ARVIs) and influenza remain poorly controlled diseases. This is due to the polyethyologicity of viruses, the mixed nature of infections, the lack of specific therapy, except for vaccination against the flu, virus antigenic variation, high contagiousness and development of antiviral drug resistance.
About the Author
N. G. Berdnikova
I.M.Sechenov Moscow Medical University;
I.V. Davydovsky City Clinical Hospital of the Moscow Department of Health
Russian Federation
PhD in medicine
Russian Federation
PhD in medicine
References
1. Shestakova IV. Antiviral drugs for the treatment of influenza from the standpoint of evidence-based medicine. The 2nd Intersociety Research and Practical Conference Infectious Diseases: Actual Issues, Treatment and Prevention, May 25-26, 2016, Moscow.
2. Popova AYu. Epidemiological updates on influenza and ARVI and scaling up readiness measures to the upcoming epidemiological season across all the Russian Federation subjects. Materials of the All-Russian Intersociety Conference on the issues of the prevention of respiratory diseases for the period of increased incidence of influenza and ARVI in 2016-2017. Access mode: http://www. rospotrebnadzor.ru.
3. Maskel N, Milar E. A guide on respiratory medicine. M.: GEOTAR Media, 2014: 234-240.
4. Selkova EP. Kalyuzhin OV. ARVI and flu. To help the practitioner. MIA 2015
5. Resolution of the Chief State Sanitary Doctor of the Russian Federation No. 70 On Measures for the Prevention of Influenza and Acute Respiratory Viral Infections in 2016-2017 Epidemiological Period, dated June 3, 2016.
6. Desheva YuA, Panchenko AV. Reduction in the acute incidence using nonspecific prophylaxis of ARVI in the epidemic period. Poliklinika. Bolezni Organov Dyhaniya, 2016, 4: 60-62.
7. Rykova SМ. Rational pharmacotherapy for acute respiratory viral infections. Consilium Medicum. Pulmonologiya, 2012, 3 (14): 26-30.
8. Rational pharmacotherapy of acute respiratory infection in the provision of primary health care. Methodical guidelines No 6. 2015
9. Methodological guidelines for the diagnosis and treatment of influenza. 2016 http://www.rospotrebnadzor.ru.
10. http://www.cochrane.org/ru/CD008965/regulyatornaya-informaciya-o-klinicheskih-ispytaniyah-oseltamivira-tamiflyu-i-zanamivira-relenza-pri-grippe-u-vzroslyh-i-detey.
11. Hsu J, Santesso N, Mustafa R et al. Antivirals for treatment of influenza. A systematic review and meta-analysis of observational studies. Ann. Intern. Med., 2012, 156: 512–524.
12. Clinical pharmacology. Edited by Acad. Kukes VG.: textbook. M: GEOTAR-Media, 2015.
13. Lazareva NB. Modern view on the problem of symptomatic treatment of acute respiratory viral infections. 2015. http://www.remedium.ru.
14. Shikh EV, Makhova AA. Vitamins in clinical practice. Edited by Kukes VG, Acad. of RAS. Prakticheskaya Meditsina, 2014: 9-45.
Review
For citations:
Berdnikova NG. Combination therapy for acute respiratory viral infections from the perspective of a clinical pharmacologist. Meditsinskiy sovet = Medical Council. 2018;(6):66-70. (In Russ.) https://doi.org/10.21518/2079-701X-2018-6-66-70
Views:
854
Email this article 